Clinical Trial

Dexamethasone-Enhanced TAP Block in Lapchole

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The transversus abdominis plane (TAP) block is widely used as part of analgesia for abdominal surgeries such as laparoscopic cholecystectomy. While bupivacaine is commonly used for TAP blocks with reported success. Dexamethasone is often used as an adjuvant in prolonging duration of blocks; however, data on its efficacy in enhancing TAP blocks in laparoscopic cholecystectomy remain limited. This study aims to assess whether adding dexamethasone to bupivacaine in a TAP block improves postoperative pain control and reduces opioid consumption
Trial Details
NCT Number NCT07182110
Lead Sponsor Makassed General Hospital
Conditions Laparoscopic Cholecystectomy
Enrollment 100 participants
Start Date 2025-08-19
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-19